CV Conduction FINAL REVIEW Flashcards
SA node is innervated by
SNS and PNS
SA node blood supply comes from
Right Coronary Artery (RCA)
% of people with SA node supplied by RCA
60%
SA node 60% provided by RCA, remaining 40% supplied by
Left Circumflex Coronary Artery ( LCA)
AV node innervated by
PNS and SNS
AV node supplied by
RCA
AV node supplied by RCA in what % of people
85-90%
AV node 85-90% provided by RCA, remaining 10-15% supplied by
Left Circumflex Coronary Artery ( LCA)
Both Right and Left Bundles receive Blood supply from branches of
Left Anterior Descending Coronary artery
LAD infarcts affect_____and _____ but rarely______, why?
LAF and RBB ; LPF, it receives additional blood supply from posterior descending coronary artery
This is why LBB blocks (LBBB) indicate more extensive cardiac disease/damage
LPF receives additional blood supply from
Posterior Descending coronary artery.
Bifascicular heart block is present when
RBBB is present with Left anterior or posterior fascicular block. Anterior is more common because posterior gets dual blood supply and is larger.
AV node allows time for
atrial contraction (atrial kick), which contributes an additional 20% to ventricular preload
Automaticity changes when
phase 4 of depolarization shifts, or resting membrane
changes
Automaticity changes: Sympathetic stimulation =
↑ slope of phase 4 of action potential and DECREASING resting membrane potential
Automaticity changes: Parasympathetic stimulation =
↓ phase 4 of action potential and INCREASING RESTING MEMBRANE POTENTION
Supraventricular (SVT) and urine
Polyuria can occur due to ↑ secretion of atrial natriuretic peptide
SVT and ANP
Occurs because AV desynchrony causes atrial contraction against closed AV valves, resulting in ↑ atrial pressures activating stretch receptors → ANP released
Triggered dysrhythmias c/ early after-depolarizations are
enhanced by slow heart rates and treated by
accelerating heart rate c/ drugs or pacing
Triggered dysrhythmias c/ delayed after-depolarizations
are
enhanced by fast heart rates and can be treated c/
drugs that lower heart rate
Sinus tachycardia and systemic diseases?
Most common supraventricular dysrhythmia associated c/ myocardial infarction (MI)
Can be a compensatory physiologic effort to ↑ cardiac output (e.g. CHF)
Sinus Tachycardia
Think twice
before treating tachycardia , may be a compensatory mechanism
Sinus tachycardia treatment
Treat underlying cause
SVT (PACs) and systemic illness
Chronic Lung disease
IHD (ischemic heart disease)
digitalis toxicity
Pathologic increase in sympathetic tone
MI, CHF PE Hyperthyroidism Pericarditis MH
Heart beating too fast, secrete
ANP to decrease BV
MAT and systemic illness
Most commonly seen in ACUTE EXACERBATION of CHRONIC LUNG DISEASE
MAT and other related systemic illness
Methylxanthine toxicity (Theophyilline and caffeine)
Heart failure
Sepsis
Metabolic/ electrolyte abnormalities
Atrial Flutter : What is it ?
Atrial flutter (A-flutter) is an organized atrial rhythm c/ a rate of 250-350 bpm c/ varying degrees of AV block
Characteristics of Atrial flutter
Rapid P waves create a sawtooth appearance called flutter waves (especially noticeable in
leads II, III, aVF, and V1)
A flutter especially noticeable in
Leads II, III, aVF, and V1
With Aflutter: Ventricular rate may be
regular or irregular depending on rate of conduction
A-flutter Ventricular rate is normally about
150 bpm
A-flutter conduction
Most commonly, pts have 2:1 AV conduction (300
atrial beats per 150 ventricular beats)
Untreated A-flutter can
Deteriorate to atrial fibrillation and revert back and forth
A-flutter is associated c/
structural heart disease
A-flutter can have
more intense symptoms than atrial fibrillation due to more rapid ventricular response
60% of pts get A-flutter c/ an acute exacerbation of a chronic condition such as (PIACET)
Pulmonary disease Infarction (MI) Acute myocardial Cardiothoracic surgery , after surgery Ethanol intoxication Thyrotoxicosis
A-flutter that is hemodynamically significant is
treated c/ synchronized cardioversion
AFlutter that is hemodynamically stable
If hemodynamically stable, overdrive pacing can be used to convert to sinus rhythm
Pts c/ A-flutter lasting longer than
48 hours must be anticoagulated or should be evaluated by TEE for an atrial thrombus before cardioversion
When treating A-flutter pharmacologically, What is the initial goal?
Common meds to control ventricular rate
include amiodarone, diltiazem, and
verapamil
ventricular control is initial goal
WIth AFLUTTER, what are you preventing? Prevents
deterioration in AV conduction to 1:1, which would cause severe hemodynamic instability (procainamide is
used in this situation)
AFlutter just transitioned to 1:1 what medication can be used ?
Procainamide
AFlutter: Common meds to control ventricular rate
include (VAD)
Verapamil
Amiodarone
Diltiazem
Anesthesia management for Aflutter
Preop and Intraop
If it occurs spontaneously before induction, cancel case
Intraoperative management depends on hemodynamic stability
Atrial fibrillation (A-Fib)occurs when
c/ a normal AV node, ventricular rates < 180
bpm
If AV node is bypassed, ventricular rates > 180
bpm (QRS complex is wide)
multiple areas of atria continuously depolarize and
contract in a disorganized manner
AFib and rhythm coordination
No coordinated depolarization or contraction,
only quivering atrial wall
AFib and Pwave
No discernable P waves
AFib and electrical input?
Irregular electrical input to AV node results in irregularly irregular ventricular contraction
Atrial fibrillation, with a normal AV node,
ventricular rates < 180 bpm
Atrial fibrillation, If AV node is bypassed,
ventricular rates > 180 bpm (QRS complex is wide)
Conditions that can lead to A-fib include: RHHICAPPA
Symptoms can be vague (generalized malaise)
or prominent, including palpitations, angina
pectoris, shortness of breath, orthopnea, and
HoTN
Rheumatic heart disease (especially mitral valve disease), HTN, Hyperthyroidism, IHD, COPD Alcohol intake (holiday heart syndrome) Pericarditis Pulmonary embolus Atrial septal defect
ATRIA anatomy that correlate c/ A-fib
↑ left atrial size and mass
AFIB Symptoms can be G- PASOH
vague (generalized malaise) or prominent, including Palpitations Angina pectoris Shortness of breath, Orthopnea HoTN
A-fib is most
common sustained cardiac dysrhythmia in general population
Incidence of AFIB
Increase with age
Most common underlying cardiovascular
diseases associated c/ A-fib are
systemic HTN and IHD
Long-term A-fib
↑ risk of heart failure is most common sustained cardiac
dysrhythmia in general population
AFib how does the conversion to thrombus occur
Loss of coordinated atrial contraction leads to stasis of blood and thrombus formation
2 most serious clinical dangers of A-fib
Atrial thrombi and thromboembolic stroke
AFIB patients require
Long-term prophylactic anticoagulation
AFIB Therapy goals include
ventricular rate control
electrical or pharmacologic cardioversion
Drugs that slow AV nodal conduction: BCD
Side effects are dose related and most commonly
include AV block and ventricular ectopy
Beta Blockers
Calcium Channel Blocking drugs
Digoxin
AFIB, β-Blockers role -PPR
Prevent recurrent A-fib
Provide good heart rate control,
Reduce symptoms during subsequent episodes of A-fib
AFIB and Calcium channel–blocking drugs : 2 drugs use
(diltiazem, verapamil)
AFIB and Calcium channel–blocking drugs role
can rapidly reduce ventricular rate during A-fib